VANCOUVER, British Columbia, July 01, 2026 (GLOBE NEWSWIRE) — Lophos Holdings Inc. ("Lophos" or the "Company") (CSE: MESC), a Canadian bioscience company focused on regulated plant-based and controlled substance opportunities, announces that the British Columbia…

VANCOUVER, British Columbia, June 11, 2026 (GLOBE NEWSWIRE) — Lophos Holdings Inc. ("Lophos" or the "Company") (CSE: MESC), a Canadian bioscience company focused on regulated plant-based and controlled substance opportunities, today provides a corporate update…

NAPANEE, Ontario, May 06, 2024 (GLOBE NEWSWIRE) — Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is pleased to announce that its wholly-owned subsidiary, Lophos Pharmaceuticals Corp. (“Lophos Pharma”) – a biosciences company specializing in…

NAPANEE, Ontario, May 02, 2024 (GLOBE NEWSWIRE) — Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is pleased to announce the official commencement of its first research protocol under its wholly-owned subsidiary, Lophos Pharmaceuticals Corp.…

VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) — Lophos Holdings Inc. (CSE: MESC) ("Lophos" or the "Company") proudly announces a milestone accomplishment from its subsidiary, Lophos Pharmaceuticals Corp. Specializing in the cultivation, research, and…